Panuveitis by Coinfection with Toxoplasma gondii and Epstein Barr Virus. Should We Use Antiviral Therapy? – A Case Report

Keyphrases

• Toxoplasma Gondii (T. gondii) 100%
• Co-infection 100%
• Antiretroviral Therapy 100%
• Panuveitis 100%
• Epstein-Barr Virus 100%
• Polymerase Chain Reaction 60%
• Intraocular Fluid 40%
• Ocular Toxoplasmosis 20%
• Appropriate Treatment 20%
• Male Patients 20%
• Intravitreal Clindamycin 20%
• Atypical Presentation 20%
• Young Males 20%
• Left Eye 20%
• Varicella Zoster Virus 20%
• Right Eye 20%
• Hypertensive Uveitis 20%
• Anti-Toxoplasma 20%
• Polymerase Chain Reaction Analysis 20%
• Toxoplasma Gondii Infection 20%
• Best-corrected Visual Acuity 20%
• Oral Corticosteroids 20%
• Diagnostic Vitrectomy 20%
• Oral Treatment 20%
• HIV-human Immunodeficiency Virus 20%
• Oral Antivirals 20%
• Superior Temporal 20%
• 60 Years Old 20%
• Congenital Cytomegalovirus (cCMV) 20%
• HSV, Herpes Simplex Virus 20%
• Virus Co-infection 20%

Medicine and Dentistry

• Epstein Barr Virus 100%
• Uveitis 100%
• Mixed Infection 100%
• Toxoplasma gondii 100%
• Antiviral Therapy 100%
• Polymerase Chain Reaction 80%
• Human immunodeficiency virus 40%
• Chorioretinopathy 40%
• Oral 40%
• Diseases 20%
• Ocular Toxoplasmosis 20%
• Toxoplasmosis 20%
• Clindamycin 20%
• Varicella Zoster Virus 20%
• Cytomegalovirus 20%
• Vitrectomy 20%
• Reaction Analysis 20%
• Case Presentation 20%
• Best Corrected Visual Acuity 20%
• Herpes Simplex Virus 20%
• Antivirus Agent 20%
• Corticosteroid 20%
• Pathogenesis 20%